<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Events: AAD Conference 2016 round up

March 17, 2016

Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients. We were delighted to present a poster at the 74th annual meeting of the American Academy of Dermatology, earlier this month. The poster, which is entitled: ‘A real world review of treatment duration and persistence among European psoriasis patients’ is authored by Research Director, Laurent Chanroux and Research Executive, Lauren Royel. 


Using patient record data taken from a survey conducted among a panel of 200 dermatologists across the main 5 EU markets, Chanroux and Royel sought to assess the duration of biologic therapy and the impact of these drugs over time, as well as measure persistence with these agents.

Contact us to request a copy of our poster.

Data sample and methodology
Detailed patient data were collected as part of an online treatment survey conducted among a panel of dermatologists between April 2014 and June 2015, across the five largest EU countries (France, Germany, Italy, Spain and the UK). Our analyses were based on a sample of 6,013 biologic experienced patients suffering from moderate to severe plaque psoriasis. 
About Therapy Watch
Therapy watch is an online syndicated market tracking tool that collects patient record data across a range of therapy areas. Therapy Watch PsO is conducted among 200 dermatologists across Europe, who submit data on moderate to severe PsO patients twice a year.

If you would like to learn more about the AAD's annual meeting, please visit: https://www.aad.org/meetings/annual-meeting

Research Partnership

Research Partnership

All the latest news from Research Partnership

Get our newsletter direct to your inbox.

Sign up to receive Rapport

Rapport is our monthly newsletter where we share our latest expertise and experience.  

Sign up here